Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
2.905
-0.105 (-3.49%)
Mar 31, 2025, 10:47 AM EDT - Market open
Fulcrum Therapeutics Revenue
In the year 2024, Fulcrum Therapeutics had annual revenue of $80.00M with 2,752.05% growth.
Revenue (ttm)
$80.00M
Revenue Growth
+2,752.05%
P/S Ratio
2.33
Revenue / Employee
$1,777,778
Employees
45
Market Cap
156.81M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
FULC News
- 26 days ago - Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Fulcrum Therapeutics, Inc. (FULC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024 - GlobeNewsWire
- 5 weeks ago - Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET - GlobeNewsWire
- 7 weeks ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics to Participate in Upcoming December Conferences - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics, Inc. (FULC) Q3 2024 Earnings Call Transcript - Seeking Alpha